TherapeuticsMD, Inc. (TXMD) Return on equity 2016–2025
TherapeuticsMD, Inc. (TXMD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-2.1%FY2025 · since FY2016: -70.5% → -2.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2.1% | +5.9 pp |
| FY2024 | -8.0% | +27.1 pp |
| FY2023 | -35.1% | -353.8 pp |
| FY2022 | 318.7% | — |
| FY2019 | -1914.4% | -1778.4 pp |
| FY2018 | -136.0% | -76.8 pp |
| FY2017 | -59.2% | +11.3 pp |
| FY2016 | -70.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice